Cargando…

HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention

BACKGROUND: Antiretroviral pre-exposure prophylaxis (PrEP) is a novel HIV prevention strategy for which adherence is a known determinant of efficacy. Blood concentrations of PrEP medications are one objective marker of adherence. METHODS: In a placebo-controlled PrEP efficacy trial of tenofovir diso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donnell, Deborah, Baeten, Jared M., Bumpus, Namandjé N., Brantley, Justin, Bangsberg, David R., Haberer, Jessica E., Mujugira, Andrew, Mugo, Nelly, Ndase, Patrick, Hendrix, Craig, Celum, Connie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAIDS Journal of Acquired Immune Deficiency Syndromes 2014
Materias:	Epidemiology and Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059553/ https://www.ncbi.nlm.nih.gov/pubmed/24784763 http://dx.doi.org/10.1097/QAI.0000000000000172

Ejemplares similares

Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study
por: Roberts, Sarah T., et al.
Publicado: (2016)

Sexual Behaviors After PrEP Discontinuation Among HIV Serodiscordant Couples in Kenya and Uganda
por: Stalter, Randy, et al.
Publicado: (2020)

Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the “PrEP as a bridge to ART” strategy
por: Musinguzi, Nicholas, et al.
Publicado: (2020)

Global implementation of PrEP for HIV prevention: setting expectations for impact
por: Pyra, Maria N, et al.
Publicado: (2019)

Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa
por: Velloza, Jennifer, et al.
Publicado: (2018)

Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda
por: Muwonge, Timothy R., et al.
Publicado: (2020)

Effect of HIV Self-Testing on PrEP Adherence Among Gender-Diverse Sex Workers in Uganda: A Randomized Trial
por: Mujugira, Andrew, et al.
Publicado: (2022)

Frequency of False Positive Rapid HIV Serologic Tests in African Men and Women Receiving PrEP for HIV Prevention: Implications for Programmatic Roll-Out of Biomedical Interventions
por: Ndase, Patrick, et al.
Publicado: (2015)

The Incremental Cost of Delivering PrEP as a Bridge to ART for HIV Serodiscordant Couples in Public HIV Care Clinics in Kenya
por: Irungu, Elizabeth M., et al.
Publicado: (2019)

High Medication Adherence During Periconception Periods Among HIV-1–Uninfected Women Participating in a Clinical Trial of Antiretroviral Pre-exposure Prophylaxis
por: Matthews, Lynn T., et al.
Publicado: (2014)

Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value
por: Abaasa, Andrew, et al.
Publicado: (2017)

Preparing for long‐acting PrEP delivery: building on lessons from oral PrEP
por: Celum, Connie, et al.
Publicado: (2023)

866. Adherence to F/TDF for PrEP in Dried Blood Spots and HIV Infection Rates: A Pooled Analysis of Global PrEP Studies
por: Liu, Albert, et al.
Publicado: (2021)

PrEP as a Lifestyle and Investment for Adolescent Girls and Young Women in Sub-Saharan Africa
por: Haberer, Jessica E., et al.
Publicado: (2019)

Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa
por: Matthews, Lynn T, et al.
Publicado: (2019)

Rethinking HIV prevention to prepare for oral PrEP implementation for young African women
por: Celum, Connie L, et al.
Publicado: (2015)

The importance of PrEP persistence in preventing HIV infections on PrEP
por: Spinelli, Matthew A, et al.
Publicado: (2020)

Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples
por: Nakku‐Joloba, Edith, et al.
Publicado: (2019)

A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago
por: Schneider, John A., et al.
Publicado: (2021)

PrEP uptake and HIV viral suppression when PrEP is integrated into Ugandan ART clinics for HIV-negative members of HIV-serodifferent couples: A stepped wedge cluster randomized trial
por: Heffron, Renee, et al.
Publicado: (2022)

Patterns of PrEP continuation and coverage in the first year of use: a latent class analysis of a programmatic PrEP trial in Kenya
por: Mugwanya, Kenneth K., et al.
Publicado: (2023)

No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda
por: Ortblad, Katrina F., et al.
Publicado: (2019)

Integrating PrEP into HIV care clinics could improve partner testing services and reinforce mutual support among couples: provider views from a PrEP implementation project in Kenya
por: Odoyo, Josephine B, et al.
Publicado: (2019)

Dynamic Perceived HIV Risk and Sexual Behaviors Among Young Women Enrolled in a PrEP Trial in Kenya: A Qualitative Study
por: Ngure, Kenneth, et al.
Publicado: (2021)

Using Behavioral Economics to Support PrEP Adherence for HIV Prevention
por: Roy Paladhi, Unmesha, et al.
Publicado: (2022)

Response to “Oral PrEP for young African women and men”
por: Celum, Connie L, et al.
Publicado: (2016)

Process evaluation of PrEP implementation in Kenya: adaptation of practices and contextual modifications in public HIV care clinics
por: Irungu, Elizabeth M., et al.
Publicado: (2021)

981. Extended Adherence and Persistence to HIV PrEP in a Multidisciplinary PrEP Clinic
por: Whelchel, Kristen, et al.
Publicado: (2020)

Scale up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya
por: Mugwanya, Kenneth K., et al.
Publicado: (2018)

Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women
por: Pyra, Maria, et al.
Publicado: (2019)

PrEP Use Among Female Sex Workers: No Evidence for Risk Compensation
por: Giguère, Katia, et al.
Publicado: (2019)

Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa
por: Hosek, Sybil, et al.
Publicado: (2016)

Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial
por: Kibengo, Freddie M., et al.
Publicado: (2013)

Brief Report: Bacterial Vaginosis and Risk of HIV Infection in the Context of CD101 Gene Variation
por: Wanga, Valentine, et al.
Publicado: (2020)

A decision support tool has similar high PrEP uptake and increases early PrEP persistence in adolescent girls and young women in South Africa: results from a randomized controlled trial
por: Celum, Connie, et al.
Publicado: (2023)

Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial
por: Celum, Connie L, et al.
Publicado: (2020)

Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women
por: Hurwitz, Kathleen E., et al.
Publicado: (2023)

Understanding the Association between PrEP Stigma and PrEP Cascade Moderated by the Intensity of HIV Testing
por: Zhang, Chen, et al.
Publicado: (2022)

Oral PrEP for HIV prevention. It works
por: Pool, Erica, et al.
Publicado: (2015)

The Safety of Tenofovir–Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B
por: Solomon, Marc M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5o9pvpj6lh0lmnkg4ia4kt47ls